Benitec Biopharma

+$0.48 (+64.86%) Today
-$0.02 (-1.64%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BNTC and other ETFs, options, and stocks.

About BNTC

Benitec Biopharma, Inc. is a development-stage biotechnology company, which focuses on the advancement of novel genetic medicines. The firms proprietary platforms includes DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration.

CEO
Jerel A. Banks
Employees
14
Headquarters
Hayward, California
Founded
2019

BNTC Key Statistics

Market cap
9.97M
Price-Earnings ratio
—
Dividend yield
—
Average volume
9.69M
High today
$1.90
Low today
$0.74
Open price
$0.74
Volume
96.70M
52 Week high
$4.78
52 Week low
$0.74

BNTC News

MarketWatchJun 24

Benitec Biopharma Shares Surge 119%, to $1.62 - MarketWatch

By Josh Beckerman Shares of Benitec Biopharma Inc., a gene therapy-focused biotechnology company, rose 119%, to $1.62, Friday. The company didn't appear to is

BNTC Earnings

-$2.45
-$1.63
-$0.82
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
— per share
Actual
Expected Sep 19, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure